Kolon TissueGene Inc
950160
Company Profile
Business description
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.
Contact
9713 Key West Avenue
Suite 300
RockvilleMD20850
USAT: +1 301 921-6000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
58
Stocks News & Analysis
stocks
ASX iron ore player downgraded ahead of earnings
Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks
Global tensions drive profitability for ASX energy provider
Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks
ASX energy share undervalued ahead of earnings
Pricing strength outweighs temporary production headwinds.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,389.10 | 43.40 | 0.46% |
| CAC 40 | 8,666.63 | 52.81 | 0.61% |
| DAX 40 | 26,202.35 | 201.04 | 0.77% |
| Dow JONES (US) | 54,085.88 | 907.47 | 1.71% |
| FTSE 100 | 10,879.38 | 21.68 | 0.20% |
| HKSE | 25,911.95 | 59.03 | 0.23% |
| NASDAQ | 26,584.99 | 671.10 | 2.59% |
| Nikkei 225 | 66,001.76 | 2,044.23 | 3.20% |
| NZX 50 Index | 13,964.69 | 61.23 | 0.44% |
| S&P 500 | 7,736.52 | 136.02 | 1.79% |
| S&P/ASX 200 | 9,211.60 | 35.10 | 0.38% |
| SSE Composite Index | 3,873.56 | 51.27 | 1.34% |